The specificity is calculated for a sensitivity of 0.75.
†95% CIs were calculated with a sensitivity of 99% and a specificity of 100% for the reverse transcription PCR.
The ICPC coding for PE (combining W81, W81.1, W81.2, and W81.3) was calculated, showing a sensitivity of 51.4% and a specificity of 100.0%.
Estimated sensitivities per patient for polyps 6 9 mm published before were 59%, 70%, 84% and 86%, respectively [ 6– 8, 10], while we calculated an estimated sensitivity of 68.1%.
Estimated sensitivities per patient for polyps ≥ 10 mm were 76%, 85%, 88% and 93%, respectively [ 6– 8, 10], while we calculated an estimated sensitivity of 83.3%.
The calculated ACR showed a sensitivity of 81.6%, specificity of 99% with a kappa coefficiency of agreement of 0.85, (95%CI 0.76, 0.95).
The overall sample size (n = 600) was calculated to demonstrate a sensitivity of 83 % and a specificity of 70%% for a one-sided type one error of 2.5 % and a power of 80%% per hypothesis.
In this data set, miR-1290 was calculated to have a sensitivity of 63.3% and 100% specificity for long-term survival in subjects with ovarian cancer (e.g., considering only people with ovarian cancer) with a PPV and a PNV of 100%and75%5%, respectively.
A meta-analysis of 8 RTE studies performed between 2005 and 2009 (639 thyroid nodules, 24% malignancies) calculated a pooled sensitivity and specificity of 92% and 90%, respectively.
